NCT04397991View on ClinicalTrials.gov

Inhaled Furosemide for Transient Tachypnea of Newborn

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

January 2, 2020

Primary Completion Date

August 1, 2021

Study Completion Date

August 1, 2021

Conditions
Respiratory Morbidity
Interventions
OTHER

Furosemide

Patients will receive nebulised furosemide solution 1 mg/kg

OTHER

Placebo

Patients will receive nebulised 0.9% saline

Trial Locations (1)

Unknown

Makassed General Hospital, Beirut

All Listed Sponsors
lead

Makassed General Hospital

OTHER

NCT04397991 - Inhaled Furosemide for Transient Tachypnea of Newborn | Biotech Hunter | Biotech Hunter